The Retracted Mifepristone Papers
Questionable research was retracted long after the damage was done in the federal court case that will allow the Supreme Court to restrict mifepristone access. We need to prevent shoddy research from getting published in the first place, but is academia capable of enforcing even the most basic scientific standards? To answer this question, we travel back to 2018, when Trump was president, Ruth Bader Ginsburg was 85 years young, and the MIT-adjacent Whitehead Institute was still enjoying its approximately $12 million dollars in fun money from federal research grants to the laboratory of one David M. Sabatini - a laboratory that published some very interesting photographs in studies of the cancer/autoimmune/abortion drug methotrexate.
Embed this episode
No transcript yet.